Black Diamond Therapeutics, Inc. (BDTX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $0.39 | +130.7% |
| 2024 | $-1.27 | +32.4% |
| 2023 | $-1.88 | +25.4% |
| 2022 | $-2.52 | +27.4% |
| 2021 | $-3.47 | -69.3% |
| 2020 | $-2.05 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $0.39 | +130.7% |
| 2024 | $-1.27 | +32.4% |
| 2023 | $-1.88 | +25.4% |
| 2022 | $-2.52 | +27.4% |
| 2021 | $-3.47 | -69.3% |
| 2020 | $-2.05 | — |